IP Library Granted Patent US 11,324,771
Granted Patent B2
US 11,324,771 · App. 16/910,560 · Granted May 10, 2022

Process for the preparation of hydroxocobalamin hydrochloride

Inventors: Ravishanker Kovi (Monroe Township, NJ); Jayaraman Kannappan (Vadodara, IN); Shivnath Patil (Dhule, IN); Chowdari Bhushaiah Talluri (Dayton, NJ); Aditya Khanvilkar (Vadodara, IN); Govind Ahirrao (Jalgaon, IN)
Assignee: RK Pharma Solutions LLC
A61K31/714C07H1/06C07H23/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,324,771
App. No.
16/910,560
Granted
May 10, 2022
Kind
B2
Abstract

A process for the preparation of hydroxocobalamin hydrochloride. More particularly the present application relates to improved process for the preparation of Hydroxocobalamin hydrochloride. In addition the present application also relates to process for the preparation of novel amorphous form. This application particularly relates to a process for the industrial manufacture of hydroxocobalamin hydrochloride from cyanocobalamin. The present application also relates to the improvement in yield with better purity of Hydroxocobalamin hydrochloride.

Claims (11)

1. A process for the purification of Hydroxocobalamin, comprising the steps of:

a. dissolving a crude hydroxocobalamin in solvent to a clear solution, wherein the crude hydroxocobalamin comprises un-reacted cyanocobalamin resulting from a formation of the crude hydroxocobalamin using a nitrate reagent and wherein the solution is prepared without using phenol chloroform;

b. treating the clear solution with resin to remove the un-reacted cyanocobalamin from the crude hydroxocobalamin;

c. filtering the treated solution to remove solid resin therefrom and using an acid adjusting the filtrate pH to 2.0-2.2;

d. re-adjusting pH using a base to 3.8-4.5 to reduce chloride content; and

e. adding anti-solvent to precipitate there from pure hydroxocobalamin.

2. The process for the purification of Hydroxocobalamin as claimed in claim 1 , wherein the resin is at least one of: Diaion HP20SS, Diaion HP20, Dowex 50w, Amberlite IRA 402(Cl), Amberlite IRA402(OH), Sephabed SP700, Amberlite IRA67 Base, DEAE sephadex, or Amberlite IR 120H/Na+.

3. The process for the purification of Hydroxocobalamin as claimed in claim 1 , wherein pH is adjusted with the acid selected from at least one of Hydrochloric Acid, H2SO4, nitric acid, carbonic acid, hydrofluoric acid, or Phosphoric acid.

4. The process for the purification of Hydroxocobalamin as claimed in claim 1 wherein pH is re-adjusted with the base selected from at least one of Sodium Hydroxide, calcium hydroxide, barium hydroxide, potassium hydroxide, strontium hydroxide, aluminium hydroxide, magnesium hydroxide, or ammonia.

5. The process for the purification of Hydroxocobalamin as claimed in claim 1 comprising treating the pure hydroxocobalamin precipitate with an alcoholic solvent to yield hydroxocobalamin in amorphous form.

6. The process for the purification of Hydroxocobalamin as claimed in claim 1 comprising precipitating Hydroxocobalamin from the solution completely.

Assignments (3)
SECURITY INTEREST Recorded May 8, 2024
From: RK PHARMA INC.
To: CITIBANK, N.A.
Reel/Frame 067343/0089 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2022
From: RK PHARMA SOLUTIONS LLC
To: RK PHARMA INC
Reel/Frame 060263/0406 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2020
From: KOVI, RAVISHANKER; KANNAPPAN, JAYARAMAN; PATIL, SHIVNATH; TALLURI, CHOWDARI BHUSHAIAH; KHANVILKAR, ADITYA; AHIRRAO, GOVIND
To: RK PHARMA SOLUTIONS LLC
Reel/Frame 054691/0621 →
Priority Claims (1)
IN 202021006047 · Feb 12, 2020 · national
Continuity (1)
Related Publication 20210252037A1 · Aug 19, 2021